These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 13930113)
1. Chlorphentermine in the management of obesity. LEVIN J; TRAFFORD JA; NEWLAND PM; BISHOP PM Practitioner; 1963 Jul; 191():65-9. PubMed ID: 13930113 [No Abstract] [Full Text] [Related]
2. [CLINICAL EVALUATION OF CHLORPHENTERMINE IN THE TREATMENT OF OBESITY]. GUREVICH I Dia Med; 1963 Dec; 35():2133-6. PubMed ID: 14113864 [No Abstract] [Full Text] [Related]
3. CURRENT THERAPEUTICS. 203. SUSTAINED-ACTION CHLORPHENTERMINE IN THE CORRECTION OF REFRACTORY OBESITY. SEATON DA; ROSE K; DUNCAN LJ Practitioner; 1964 Nov; 193():698-702. PubMed ID: 14225574 [No Abstract] [Full Text] [Related]
4. [Clinical study of a new appetite depressor: S-62, devoid of cortical excitant action (-1(p-chlorophenyl)-2-methyl-2-aminopropane HC1 (chlorphentermine)]. RIVIERE J J Med Bord; 1962 May; 139():559-64. PubMed ID: 14492582 [No Abstract] [Full Text] [Related]
5. [CLINICAL STUDY OF AN ANOREXIGEN WITH PROLONGED EFFECT (S 62-2-CHLORPHENTERMINE) (APROPOS OF 30 OBSERVATIONS)]. HURIET C Ann Med Nancy; 1964 Dec; 3():1485-91. PubMed ID: 14268811 [No Abstract] [Full Text] [Related]
6. OBESITY TREATMENT OF COMPLICATED AND UNCOMPLICATED CASES WITH CHLORPHENTERMINE HYDROCHLORIDE. BERRY RL Ind Med Surg; 1965 Jun; 34():490-2. PubMed ID: 14308330 [No Abstract] [Full Text] [Related]
7. CHLORPHENTERMINE S.A. IN THE TREATMENT OF OBESITY AND THE EFFECT OF WEIGHT LOSS ON STEROID EXCRETION. JACKSON IM; WHYTE WG Br Med J; 1965 Aug; 2(5459):453-5. PubMed ID: 14314911 [No Abstract] [Full Text] [Related]
9. Chlorphentermine: a new "appetite suppressant". A cross-over double-blind trial. LUCEY C; HADDEN DR Ulster Med J; 1962 Dec; 31(2):181-4. PubMed ID: 13931448 [No Abstract] [Full Text] [Related]
11. [Chlorphentermine in the treatment of obesity]. Chjnowski JR; Adamska-Dyniewska H; Leszczyński B; Mockallo T Pol Tyg Lek; 1968 Sep; 23(40):1531-3. PubMed ID: 5725611 [No Abstract] [Full Text] [Related]
12. [CLINICAL TRIAL OF AN ANOREXIGENIC AGENT (CHLORPHENTERMINE) PRESENTED IN LONG-ACTING TABLETS]. VAGUE J; TEITELBAUM M; MILLER G Sem Hop; 1964 May; 40():1376-81. PubMed ID: 14143418 [No Abstract] [Full Text] [Related]
13. [Patterns of glucose and pyruvate curves during treatment of obesity with chlorphentermine (Avipron)]. Adamska-Dyniewska H; Kowalczyk L Wiad Lek; 1968 Nov; 21(21):1901-4. PubMed ID: 5714921 [No Abstract] [Full Text] [Related]
14. Comparative study of anorectic activity of d-amphetamine, chlorphentermine and fenfluramine in aurothioglucose obese and non-obese mice. Abdallah AH Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):395-402. PubMed ID: 5715411 [No Abstract] [Full Text] [Related]
15. [ACCIDENTAL POISONING WITH CHLORPHENTERMINE ("AVICOL") IN A SMALL CHILD]. BOSCH HJ; BEYER KH Arch Toxikol; 1965 Feb; 20():274-8. PubMed ID: 14272413 [No Abstract] [Full Text] [Related]
16. Chlorphentermine and phenmetrazine compared: weight reduction, side effects and psychological change. Sletten IW; Sundland D; Pichardo J; Viamontes G Mo Med; 1967 Nov; 64(11):927-9. PubMed ID: 6056101 [No Abstract] [Full Text] [Related]
17. [Experience with a Hungarian-made chlorphentermine-type anorexigenig preparation (Desopimon) in the treatment of hypothalamopathies]. Takács L; Pethö B Orv Hetil; 1969 Mar; 110(10):540-2. PubMed ID: 5779971 [No Abstract] [Full Text] [Related]
18. TDrug therapy in obesity. Ruedy J Mod Treat; 1967 Nov; 4(6):1138-45. PubMed ID: 6080141 [No Abstract] [Full Text] [Related]
19. Weight reduction with phenmetrazine and chlorphentermine a double-blind study. Hadler AJ Curr Ther Res Clin Exp; 1967 Nov; 9(11):563-9. PubMed ID: 4965505 [No Abstract] [Full Text] [Related]
20. Desopimon in the management of obesity associated with heart disease. Gonda F; Kenedi I Ther Hung; 1973; 21(2):82-4. PubMed ID: 4792883 [No Abstract] [Full Text] [Related] [Next] [New Search]